referring to fig1 and 6 , a preferred form is shown of the vascular sealing device 10 for effecting closure of a puncture in a blood vessel which has been entered through percutaneous techniques . the device 10 is useable with a procoagulant which is injected through a standard percutaneous vascular sheath or introducer . the vascular sealing device 10 is shown to have an elongated thin , generally tubular body or conduit 15 with proximal and distal ends 11 and 12 , respectively . basically , the proximal end 11 of the device 10 is for physician manipulation and connection to associated medical apparatus described further below , while the distal end 12 is for insertion into the patient &# 39 ; s body . located at the proximal end 11 of device 10 is an inflation / deflation port 14 . the body member 15 has a tubular structure constructed of hypotubing or a similar material . this structure also has a cylindrical and thin outer body wall with a central , continuous , and longitudinally extending lumen 28 . the body member 15 has an outside diameter preferably not greater than 0 . 038 inches ( 0 . 965 mm .). the body 15 is semiflexible and , importantly , has a predetermined rigidity such that central lumen 28 integrity is maintained . this is particularly important during longitudinal translational manipulation by the physician , through vascular introducer means ( described below ), into a percutaneous puncture in the patient &# 39 ; s skin . the hypotubing of the body 15 is preferably constructed of a metallic material such as stainless steel , for example . alternatively , the body 15 may be constructed of a polymeric material . the body member 15 is shown to have a length preferably of at least 11 . 79 inches ( 30 cm ). the proximal end 11 of the lumen or hollow interior 28 is sealed with elastomeric material , preferably silicone , to form an inflation / deflation port 14 . the seal forms the inflation / deflation port 14 by adhering to the internal wall surfaces of the proximal end 11 of body 15 . the seal is of sufficient strength to maintain a pressure difference between the internal lumen 28 and the proximally disposed exterior of the seal . this pressure difference is of a magnitude sufficient to maintain inflation of the balloon 34 , which is in continuity with the lumen 28 . the inflation / deflation port 14 is utilized by piercing its proximal face , preferably with a syringe needle , to a depth which allows the needle lumen to be in continuity with the lumen 28 . an external syringe , attached to the proximal end of the needle , provides a piston means by which a gas or liquid is pumped into the balloon 34 for inflation , or out of the balloon 34 for deflation . removal of the needle from the inflation / deflation port 14 causes the seal to reestablish the pressure differential barrier . the structure of the proximal end 11 also allows the user to later slide a standard vascular sheath over the device body 15 and then to advance it to the puncture site for positioning within the blood vessel lumen . this allows reentry into the blood vessel , if necessary , for a further interventional procedure . the bottom or distal end 12 of the device body 15 is shown to have a distal tip 29 . the distal tip 29 further has an inset segment 32 . the inset segment 32 has a tubular configuration and is oriented coaxially with respect to the distal tip 29 . the inset segment 32 preferably has a diameter which is less than that of the distal tip 29 and a length equivalent to that of the wall of the balloon 34 when deflated . thus , an inset with respect to the distal tip 29 is formed by this structure . the lumen 28 extends into the inset segment 32 and is communicatively connected to an orifice 33 , which is disposed in the side wall of the inset segment 32 . the orifice 33 is shown to have a circular configuration . referring to fig1 a and b , the balloon 34 is disposed about the inset segment 32 . in an uninflated state , the balloon 34 has a tubular configuration and is sealingly secured at each of its ends to respective ends 30 and 31 of the inset segment 32 . sealing securement may be made by various methods , including adhesives , ultrasonic welding , and compression fitting . the uninflated diameter of the balloon 34 is such that it is disposed substantially within the recess space formed by the difference in diameter of the inset segment 32 and the distal tip 29 . this provides a low profile device diameter which reduces vascular trauma and puncture site diameter upon removal . in an inflated state the balloon 34 preferably assumes a rounded configuration , for example elliptical with a minimum inflated diameter of two times the french size of the introducer sheath puncture hole being sealed . in addition , the height or thickness of the inflated balloon 34 is preferably less than one half the diameter of a typical blood vessel being sealed , so as to minimize obstruction of flow through the blood vessel . the balloon 34 is preferably constructed of an expandable material such as natural latex . a flexible atraumatic extension 37 is shown disposed at the distal end 12 of the vascular sealing device 10 , extending from the inset segment 32 . the extension 37 preferably has a tubular structure with a diameter equivalent to that of distal tip 29 . importantly , the extension 37 is formed of a flexible material such as guidewire as known in the art . the extension 37 is shown to have an end portion which is preferably curved in its inoperative state . this structure decreases the level of trauma to the vessel wall during insertion and manipulation of the device 10 . referring to fig1 refers to a distance marker upon body 15 for the purpose of indicating to the user that the balloon 34 is distal to the sheath taper end 48 shown in fig2 and 3 . by alignment of marker 81 at the top of the hemostatic valve opening at cap 45 , proper location of the balloon 34 with respect to sheath tapered end 48 is assured . referring generally to fig2 - 5 , in use , the vascular sealing device 10 is inserted into the input end 45 of an introducer or vascular sheath device 43 which has been previously positioned within the lumen 58 of a blood vessel 56 . the typical introducer 43 , as is well known , comprises a body structure 46 , an elongated sheath 47 with a tapered end 48 , a hemostatic ingress / egress valve 80 within a cap 45 , an auxiliary tube 44 and a suture connector 49 which may be used to maintain the introducer 43 in an operative position on the patient &# 39 ; s skin surface 55 for prolonged periods of time and to thereby permit reaccess to the patients vascular system 56 . the body 46 of the introducer 43 remains on the exterior of the patient &# 39 ; s body at all times , while the sheath 47 extends through puncture 60 in the skin surface 55 , tissue 59 , and vessel wall 57 . the vascular sealing device 10 is first inserted through the valve or gasket 80 of the introducer 43 , distal end 12 first , and is advanced by physician manipulation of the body member 15 , primarily , until the distal end 12 extends just beyond the distal tapered tip 48 of the sheath 47 . next , an inflator such as a syringe ( not shown ) pierces the inflation / deflation port 14 of device 10 . fluid or gas is advanced into the device 10 until a predetermined amount of balloon 34 inflation is attained . then , the inflating means is removed . next , the inflated balloon section 34 is pulled up against the vessel wall 56 at the puncture site 60 , by manipulating the body member 15 . at this point in the procedure , a hemostatic seal is effected at the puncture site 60 . next , and importantly , a procoagulant is injected through a fluid access port 44 of the introducer 43 and is released out its distal end 48 at the puncture site 60 . next , the introducer sheath 47 is withdrawn by manipulation of the introducer body 46 and sheath 47 proximal end . the balloon section 34 remains abutted against the inner intraluminal surface 56 of the puncture site 60 . after a predetermined time period , on the order of 1 - 3 minutes , the balloon 34 is deflated and the device 10 is pulled proximally out of the puncture site 60 . the procoagulant may include one of the following substances or combinations of substances : ( 1 ) thrombin , ( 2 ) collagen , ( 3 ) fibrin / fibrinogen , ( 4 ) cyanoacrylate , ( 5 ) thrombin and collagen , ( 6 ) fibrin / fibrinogen and collagen , ( 7 ) cyanoacrylate and collagen , and ( 8 ) thrombin and fibrin / fibrinogen . the advantages of the device 10 and method of the present invention include , but are not limited to , both individually and cooperatively , ( 1 ) that the inflated balloon 34 blocks egress of blood immediately upon being properly positioned in the blood vessel at the puncture site to provide fast hemostasis ; ( 2 ) that the inflated balloon 34 acts as an internal marker to permit the user to accurately gauge the depth of the puncture and the thickness of the tissues surrounding the puncture ; and ( 3 ) that the inflated balloon 34 acts as a backstop at the inner wall of the blood vessel to ( i ) precisely position the sealing clot in the puncture and ( ii ) to prevent procoagulant from entering the patient &# 39 ; s circulatory system . the descriptions above and the accompanying drawings should be interpreted in the illustrative and not the limited sense . while the invention has been disclosed in connection with the preferred embodiment or embodiments thereof , it should be understood that there may be other embodiments which fall within the scope of the invention as defined by the following claims . where a claim is expressed as a means or step for performing a specified function it is intended that such claim be construed to cover the corresponding structure , material , or acts described in the specification and equivalents thereof , including both structural equivalents and equivalent structures .
a device for sealing an opening or puncture in the wall of a blood vessel or other percutaneous openings . the device includes a shaft section member of a small diameter , with an expandable balloon and atraumatic tip at its distal end . the proximal end of the device has an inflation / deflation port which is utilized to inflate the balloon once it is in place within the blood vessel or other body cavity . the entire device is placed through a hemostasis vascular introducer or sheath , which is used during invasive percutaneous vascular procedures . the balloon is inflated and withdrawn until it engages the inner surface of the blood vessel . a procoagulant is injected via the introducer to the puncture . after a predetermined time period , the balloon is deflated and the device is withdrawn .